Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

as always you find an amazing array of helpful info; thanks again for reading material.

The word of caution regarding Kevetrin is simple: short half life means no real chance to demonstrate efficacy thus far, but also, perhaps, no real chance to demonstrate adverse effects. I have written on the board before about the lifespans of white blood cells as one possible problem- this was an issue with MDM/X drugs .

When will the add on to phase 1 start? What will it show? Kevetrin safe so far in phase 1 with a very short half life drug given WEEKLY! what is next and how long will it all take?( Yes I know I keep writing the same thing - but it is critical info)